Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alarmins (IL-33, sST2, HMGB1, and S100B) as potential biomarkers for schizophrenia
Elżbieta Kozłowska, Ewa Brzezińska‐Błaszczyk, Justyna Agier, et al.
Journal of Psychiatric Research (2021) Vol. 138, pp. 380-387
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

The Microbiota–Gut–Brain Axis in Psychiatric Disorders
Aleksandra Góralczyk-Bińkowska, Dagmara Szmajda‐Krygier, Elżbieta Kozłowska
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11245-11245
Open Access | Times Cited: 232
The role of damage associated molecular pattern molecules (DAMPs) and permeability of the blood-brain barrier in depression and neuroinflammation
María Fernanda Serna-Rodríguez, Sofía Bernal‐Vega, José Alfonso Ontiveros-Sánchez de la Barquera, et al.
Journal of Neuroimmunology (2022) Vol. 371, pp. 577951-577951
Closed Access | Times Cited: 60
Bridging the gap: associations between gut microbiota and psychiatric disorders
Gellan K. Ahmed, Haidi Karam‐Allah Ramadan, Khaled Elbeh, et al.
Middle East Current Psychiatry (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 8
Circulating Cell-Free DNA Levels in Psychiatric Diseases: A Systematic Review and Meta-Analysis
Mark M. Melamud, Valentina N. Buneva, Evgeny A. Ermakov
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3402-3402
Open Access | Times Cited: 19
Unraveling the potential of neuroinflammation and autophagy in schizophrenia
Hongxia Tao, Cheng‐Xiang Wang, Chuan Zou, et al.
European Journal of Pharmacology (2025) Vol. 997, pp. 177469-177469
Closed Access
LRFN5 and OLFM4 as novel potential biomarkers for major depressive disorder: a pilot study
Ke Xu, Peng Zheng, Shuang Zhao, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Relationships between schizophrenia and the alarmins interleukin-33 (IL-33), soluble receptor of interleukin-33 (sST2) and the ratio IL-33/sST2. A systematic review.
José Juan Tascón-Cervera, María Luisa Fernández-López, A.M. Morera
Journal of Psychiatric Research (2025)
Closed Access
Correlations between omega-3 fatty acids and inflammatory/glial abnormalities: the involvement of the membrane and neurotransmitter dysfunction in schizophrenia
Yongping Zhang, Jingwen Yin, Haifeng Yan, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 10
Human umbilical cord blood mesenchymal stem cells mediate microglia activation and improve anxiety-like behavior in MIA-induced offspring of schizophrenic rats
Xiangzheng Cui, Tengfei Chen, Yongjiang Xue, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 133, pp. 111010-111010
Closed Access | Times Cited: 3
Plasma biomarkers in adolescents with schizophrenia‐spectrum disorder
Przemysław Zakowicz, Maria Skibińska, Filip Waśniewski, et al.
Early Intervention in Psychiatry (2023) Vol. 17, Iss. 12, pp. 1154-1161
Open Access | Times Cited: 7
Comparison of HMGB1, RAGE, TLR4, and NF-κB levels in children and adolescents diagnosed with autism spectrum disorder with healthy controls
Esra Kıyat, Evrim Aktepe, Duygu Kumbul Doğuç, et al.
International Journal of Developmental Disabilities (2024), pp. 1-8
Closed Access | Times Cited: 2
Peripheral S100B Protein Levels in Five Major Psychiatric Disorders: A Systematic Review
Tomasz Kozłowski, Weronika Bargieł, Maksymilian Grabarczyk, et al.
Brain Sciences (2023) Vol. 13, Iss. 9, pp. 1334-1334
Open Access | Times Cited: 6
A scoping review of protein biomarkers for schizophrenia: state of progress, underlying biology, and methodological considerations
Caio Henrique de Souza Ferreira Berdeville, Danyelle Silva-Amaral, Paulo Dalgalarrondo, et al.
Neuroscience & Biobehavioral Reviews (2024), pp. 105949-105949
Closed Access | Times Cited: 2
Schizophrenia and Alarmins
Huan Ma, Ning Cheng, Caiyi Zhang
Medicina (2022) Vol. 58, Iss. 6, pp. 694-694
Open Access | Times Cited: 9
Vascular-related biomarkers in psychosis: a systematic review and meta-analysis
Xiaojun Li, Shuang Hu, Pozi Liu
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 5
Deviant spontaneous neural activity as a potential early-response predictor for therapeutic interventions in patients with schizophrenia
Huan Jing, Chunguo Zhang, Haohao Yan, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 5
The relationship between inflammatory markers, clinical characteristics, and cognitive performance in drug-naïve patients with schizophrenia
Xiaoxiao Sun, Guoshuai Luo, Xue Li, et al.
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 274, Iss. 6, pp. 1365-1374
Closed Access | Times Cited: 5
Advanced Biomarkers of Hepatotoxicity in Psychiatry: A Narrative Review and Recommendations for New Psychoactive Substances
Aniela Golub, Michał Ordak, Tadeusz Nasierowski, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9413-9413
Open Access | Times Cited: 4
Serum IL-33 as a biomarker in different diseases: useful parameter or much need for clarification?
Stefan Erfurt, Meike Hoffmeister, Stefanie Oess, et al.
Journal of Circulating Biomarkers (2021) Vol. 10, pp. 20-25
Open Access | Times Cited: 10
Diminished treatment response in relapsed versus first-episode schizophrenia as revealed by a panel of blood-based biomarkers: A combined cross-sectional and longitudinal study
Hualin Cai, Cuirong Zeng, Xiangyang Zhang, et al.
Psychiatry Research (2022) Vol. 316, pp. 114762-114762
Closed Access | Times Cited: 7
Potential Inflammatory Biomarker in Patients with Attention Deficit Hyperactivity Disorder
Ji Hyun Park
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13054-13054
Open Access | Times Cited: 7
Potential Inflammatory Biomarker in Patients with Attention Deficit Hyperactivity Disorder
Ji Hyun Park
(2022)
Open Access | Times Cited: 6
Serum s100b protein levels as a neuroinflammatory biomarker of acutely relapsed paranoid schizophrenia patients
A.M. Morera, E. Díaz-Mesa, Lourdes Fernández-López, et al.
Acta Neuropsychiatrica (2022) Vol. 35, Iss. 3, pp. 138-146
Open Access | Times Cited: 6
Systematic Review and Meta-Analysis of Damage Associated Molecular Patterns HMGB1 and S100B in Schizophrenia
Michael Mackey, Laurena Holleran, Gary Donohoe, et al.
Psychiatry Investigation (2022) Vol. 19, Iss. 12, pp. 981-990
Open Access | Times Cited: 6
IDH2/PPARγ pathway as a novel diagnostic biomarker panel for schizophrenia
Ke Xu, Xinyu Zhou, Yi Ren, et al.
Asian Journal of Psychiatry (2023) Vol. 89, pp. 103788-103788
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top